Pharmaceutical News

RSS

Wolters Kluwer sells pharma-related business to Springer Science+Business Media

Wolters Kluwer, a market-leading global information services company focused on professionals, today announced that it has completed the sale of its pharma-related Marketing & Publishing Services business to Springer Science+Business Media.

26 Dec 2011

FDA accepts Gilead's Quad HIV regimen NDA for review

Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.

26 Dec 2011

TheraBiogen launches Social Media campaign

TheraBiogen, Inc., a manufacturer and distributor of homeopathic nasal sprays for aiding in the relief of allergies, cold and flu symptoms and migraine headaches, announced today the launch of its Social Media campaign as part of its ongoing product marketing program.

26 Dec 2011

Researchers report how sildenafil can alleviate heart problems

How sildenafil, the active ingredient in Viagra, can alleviate heart problems is reported by Bochum's researchers in cooperation with colleagues from the Mayo Clinic in Rochester (Minnesota) in the journal Circulation.

26 Dec 2011

FDA EMDAC schedules to review VIVUS' Qnexa NDA for treatment of obesity

VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review the Company's New Drug Application (NDA) for Qnexa for the treatment of obesity on February 22, 2012.

26 Dec 2011

Researchers report how sildenafil can alleviate heart problems

23 Dec 2011

ARV drugs can prevent transmission of HIV

The finding of a team of researchers - including several members from Johns Hopkins - that HIV treatment with antiretroviral drugs (ARVs) can actually prevent transmission of the virus from an infected person to his or her uninfected partner has been named "Breakthrough of the Year" for 2011 by the journal Science.

23 Dec 2011

N.Y. Times review finds misuse of psychotropic drugs in disabled patients

Tens of thousands of powerful pills created to treat serious mental illnesses like schizophrenia are given to developmentally disabled people in the care of New York State every day.

23 Dec 2011

Injected meth users at greater risk of attempting suicide

The dire physical and mental health effects of injecting methamphetamine are well known, but there's been little research about suicidal behavior and injecting meth.

23 Dec 2011

Veloxis, Athena partner to establish competitive presence for AtorFen in emerging markets

Veloxis Pharmaceuticals and Athena Drug Delivery Solutions Pvt. Ltd. today announced an alliance whereby Athena will obtain exclusive rights in certain emerging market territories to manufacture and, with third parties, develop, register and commercialize Veloxis' AtorFen (Fenofibrate Atorvastatin fixed dose combination).

23 Dec 2011

BBC News Magazine examines antiviral drug research

BBC News Magazine examines an antiviral drug called Draco, developed by Todd Rider, a research scientist at the Massachusetts Institute of Technology, "which has proven successful against all 15 viruses to which it has been applied in lab trials with human tissue and mice," including "the common cold, H1N1 or swine flu, a polio virus, dengue fever, and the notorious and fatal Ebola virus."

23 Dec 2011

Anti-cancer drugs may also fight antibiotic resistance

Drugs used to overcome cancer may also combat antibiotic resistance, finds a new study led by Gerry Wright, scientific director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University.

23 Dec 2011

Researchers reveal what cells respond to anesthesia in C. elegans

Physicians use inhalation anesthetics in a way that is incredibly safe for patients, but very little is known about the intricacies of how these drugs actually work in children and adults. Now, researchers have uncovered what cells respond to anesthesia in an organism known as the C. elegans, according to a new study from the Seattle Children's Research Institute. C. elegans is a transparent roundworm used often in research.

23 Dec 2011

Walgreen expecting sharp drop in prescription business

A contract dispute with pharmacy benefit manager Express Scripts is likely to cut the number of drugs Walgreen will sell.

23 Dec 2011

Religious leaders should come together to ensure access to NTD medicines for world's poorest

Most of the world's neglected tropical diseases occur among populations that adhere to Islam, Catholicism, or Hinduism, an observation that "affords an opportunity to establish a unique interfaith dialogue among religious leaders" leading to global action, Peter Hotez, president of the Sabin Vaccine Institute, and Serap Aksoy, a professor at the Yale School of Public Health, write in a PLoS Neglected Tropical Diseases (NTD) editorial.

23 Dec 2011

$First study to explore impact of crowding on children with fracture-related pain$

First study to explore impact of crowding on children with fracture-related pain

Crowding in hospital emergency departments has led to a decrease in the timely and effective use of pain medication in children suffering acute long bone fractures, according to a new study by the University of Colorado School of Medicine.

23 Dec 2011

Russia will not use HIV spending to fund needle exchange, methadone therapy, Reuters reports

Though Russia is doubling its budget for HIV in 2012 over 2010 levels, "no money will go to such internationally recognized efforts as needle exchanges" and methadone replacement therapy, Reuters reports.

23 Dec 2011

Momenta, Baxter partner to develop and commercialize biosimilars

Baxter International Inc. and Momenta Pharmaceuticals, Inc. today announced that they have entered into a global collaboration to develop and commercialize follow-on biologic products, also known as biosimilars.

From Baxter International Inc. 23 Dec 2011

Oak Pharmaceuticals acquires three Lundbeck hospital-based injectables

Akorn, Inc., a niche generic pharmaceutical company, today announced that its wholly-owned subsidiary, Oak Pharmaceuticals, has acquired three off-patent, branded, hospital-based injectables from the US subsidiary of H. Lundbeck A/S.

23 Dec 2011

Botox can have unsuspected 'systemic' effects on muscles

Botulinum neurotoxin type A—better known as Botox—has previously unsuspected 'systemic' effects on muscles other than the ones it's injected into, reports a study in the January issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

23 Dec 2011